Literature DB >> 12598455

Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis.

R F Degenring, J B Jonas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12598455      PMCID： PMC1771553          DOI： 10.1136/bjo.87.3.361

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.

Authors:  G J Jaffe; J Ben-Nun; H Guo; J P Dunn; P Ashton
Journal:  Ophthalmology       Date:  2000-11       Impact factor: 12.079

2.  Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy.

Authors:  A Martidis; J S Duker; C A Puliafito
Journal:  Arch Ophthalmol       Date:  2001-09

3.  Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.

Authors:  S Young; G Larkin; M Branley; S Lightman
Journal:  Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 4.207

4.  Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

Authors:  R J Antcliff; D J Spalton; M R Stanford; E M Graham; T J ffytche; J Marshall
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

5.  Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

Authors:  J B Jonas; A Söfker
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

6.  Treatment of intraocular proliferations with intravitreal steroids.

Authors:  R Machemer; G Sugita; Y Tano
Journal:  Trans Am Ophthalmol Soc       Date:  1979
  6 in total
  21 in total

1.  Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 2.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema.

Authors:  Abdullah Ozkiris; Cem Evereklioglu; Ayse Oner; Kuddusi Erkiliç
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

4.  Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; P Hugger; G Sauder; S Panda-Jonas; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

5.  Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

Authors:  J B Jonas; I Akkoyun; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 6.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Examination of purification methods and development of intravitreal injection of triamcinolone acetonide.

Authors:  Masako Oishi; Shinichiro Maeda; Ayumi Nakamura; Nobuo Kurokawa; Nobuyuki Ohguro; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

8.  Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors.

Authors:  Ziad F Bashshur; Abdallah M Terro; Christelle P El Haibi; Akaber M Halawi; Alexandre Schakal; Baha' N Noureddin
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Intravitreal triamcinolone for intraocular inflammation and associated macular edema.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  [Intraocular triamcinolone for diffuse diabetic macular edema].

Authors:  R F Degenring; I Kreissig; J B Jonas
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.